BlackRock Health Sciences Trust Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for BlackRock Health Sciences Trust.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Capital Markets earnings growth | 15.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
BME: Trading At A Historical Discount To NAV
Apr 05BME: Historically One Of The Best Times For Entry
Nov 28BME: BlackRock's Health Sciences Fund Is A Solid Alternative To Pricey THW
Sep 17BME Offers A Good Mix Of High Yield And Market-Beating Total Returns
Jul 03BME: Well-Positioned Healthcare CEF For Monthly Income
Feb 10BlackRock Health Sciences Trust declares $0.213 dividend
Dec 12BlackRock Health Sciences Trust goes ex-dividend on Monday
Nov 11BlackRock Health Sciences Trust declares $0.213 dividend
Oct 06BME: Overpriced Health-Care CEF, Paltry 6% Yield
Sep 21BlackRock Health Sciences Trust declares $0.213 dividend
Sep 02BlackRock Health Sciences Trust declares $0.213 dividend
Aug 05BME And BMEZ: 2 Quite Different Choices
Jul 26BlackRock Health Sciences Trust declares $0.213 dividend
Jul 05BME: Good Times, Bad Times, A Fund For All Times
Apr 24BME: High Concentration In Large Cap Led To Huge Downfall
Mar 03BMEZ: We Own BME, But Here's Why We're Buying BlackRock Health Sciences Trust II
Dec 24BME: High Yield And Strong Growth From Healthcare
Dec 14BlackRock Health Sciences: Clever Options Strategies And Asset Allocation
Sep 19Evaluating CEFs: BME Offers Good Income In A Hot Sector
Jun 18BlackRock Health Sciences Trust declares $0.20 dividend
May 07BlackRock Health Sciences Trust declares $0.20 dividend
Feb 04BlackRock Health Sciences Trust declares $0.20 dividend
Jan 05BME: Monthly Dividends Plus Growth
Dec 15BlackRock Health Sciences Trust declares $0.20 dividend
Dec 04BlackRock Health Sciences Trust declares $0.20 dividend
Nov 03In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as BlackRock Health Sciences Trust has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 8 | 20 | 32 | 32 | N/A |
| 9/30/2023 | 8 | 34 | 24 | 24 | N/A |
| 6/30/2023 | 8 | 47 | 15 | 15 | N/A |
| 3/31/2023 | 8 | 10 | 7 | 7 | N/A |
| 12/31/2022 | 8 | -26 | -1 | -1 | N/A |
| 9/30/2022 | 7 | -35 | -2 | -2 | N/A |
| 6/30/2022 | 7 | -43 | -4 | -4 | N/A |
| 3/31/2022 | 7 | 8 | -13 | -13 | N/A |
| 12/31/2021 | 6 | 59 | -22 | -22 | N/A |
| 9/30/2021 | 6 | 84 | -23 | -23 | N/A |
| 6/30/2021 | 6 | 109 | -25 | -25 | N/A |
| 3/31/2021 | 5 | 94 | -22 | -22 | N/A |
| 12/31/2020 | 5 | 80 | -19 | -19 | N/A |
| 9/30/2020 | 5 | 67 | -18 | -18 | N/A |
| 6/30/2020 | 5 | 55 | -16 | -16 | N/A |
| 3/31/2020 | 5 | 67 | -15 | -15 | N/A |
| 12/31/2019 | 5 | 80 | -14 | -14 | N/A |
| 9/30/2019 | 5 | 59 | -17 | -17 | N/A |
| 6/30/2019 | 5 | 39 | -19 | -19 | N/A |
| 3/31/2019 | 5 | 31 | -9 | -9 | N/A |
| 12/31/2018 | 5 | 22 | 2 | 2 | N/A |
| 9/30/2018 | 4 | 28 | 5 | 5 | N/A |
| 6/30/2018 | 4 | 34 | 9 | 9 | N/A |
| 3/31/2018 | 4 | 47 | 4 | 4 | N/A |
| 12/31/2017 | 4 | 60 | -1 | -1 | N/A |
| 9/30/2017 | 4 | 50 | N/A | 0 | N/A |
| 6/30/2017 | 3 | 39 | N/A | 1 | N/A |
| 3/31/2017 | 3 | 11 | N/A | 5 | N/A |
| 12/31/2016 | 3 | -16 | N/A | 10 | N/A |
| 9/30/2016 | 3 | -18 | N/A | 25 | N/A |
| 6/30/2016 | 3 | -21 | N/A | 41 | N/A |
| 3/31/2016 | 3 | 6 | N/A | 40 | N/A |
| 12/31/2015 | 3 | 33 | N/A | 40 | N/A |
| 12/31/2014 | 3 | 50 | N/A | 115 | N/A |
| 10/31/2014 | 3 | 71 | N/A | 27 | N/A |
| 7/31/2014 | 3 | 61 | N/A | N/A | N/A |
| 4/30/2014 | 3 | 50 | N/A | 26 | N/A |
| 1/31/2014 | 4 | 60 | N/A | 22 | N/A |
| 10/31/2013 | 4 | 69 | N/A | 18 | N/A |
| 7/31/2013 | 4 | 61 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BME's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if BME's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if BME's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if BME's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if BME's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BME's Return on Equity is forecast to be high in 3 years time